BROOKS vs WOCKPHARMA: Stock Comparison

BROOKS vs WOCKHARDTUpdated 16 Apr 26, 4:01 PM ISTNSE & company filings

WOCKHARDT is the larger company by market capitalisation. BROOKS shows a lower P/E, lower leverage and a higher net margin, while WOCKHARDT shows a higher ROE, faster revenue growth and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

BROOKS leads 5; WOCKPHARMA leads 6 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

BROOKSWOCKPHARMA

Valuation lens

What price are you paying?

Market CapContext only
₹194 Cr
₹33,908 Cr
P/E RatioBROOKS has the lower reading
8.22x
75.68x
P/B RatioBROOKS has the lower reading
1.65x
6.27x
EPSWOCKPHARMA has the higher reading
₹-0.61
₹6.58
Book ValueContext only
₹41.64
₹325
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
WOCKPHARMA is the larger company
₹33,908 Cr vs ₹194 Cr
P/E Ratio
BROOKS has a lower P/E
8.22x vs 75.68x
P/B Ratio
BROOKS has a lower P/B
1.65x vs 6.27x
EPS
WOCKPHARMA has higher earnings per share
₹6.58 vs ₹-0.61
Revenue Growth (TTM YoY)
WOCKPHARMA has faster revenue growth
26% vs -6.37%
Qtr Sales Growth
BROOKS has stronger quarterly sales growth
0% vs -39.61%
Qtr Profit Growth
WOCKPHARMA has stronger quarterly profit growth
0% vs -225.96%
ROE
WOCKPHARMA has a higher ROE
10.28% vs 4.8%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricBROOKSWOCKPHARMA
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricBROOKSWOCKPHARMA
Live Price₹69.58₹2,088.7
Day Change-3.45%7.08%
Volume91,99935.58 L
52-Week High₹163.9₹2,422.3
52-Week Low₹36.3₹1,086.7
Distance from 52W High-57.55%-13.77%

Valuation

MetricBROOKSWOCKPHARMA
Market Cap₹194 Cr₹33,908 Cr
P/E Ratio8.22x75.68x
P/B Ratio1.65x6.27x
EPS₹-0.61₹6.58
Book Value₹41.64₹325
Dividend Yield0%0%

Growth

MetricBROOKSWOCKPHARMA
Revenue Growth (TTM YoY)-6.37%26%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth0%-39.61%
Qtr Profit Growth-225.96%0%

Profitability & Leverage

MetricBROOKSWOCKPHARMA
ROE4.8%10.28%
ROCE5.46%10.37%
Net Margin28.67%3.3%
Operating Margin7.74%28.35%
Debt to Equity0.06x0.57x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricBROOKSWOCKPHARMA
Promoter Holding52.62%49.08%
FII Holding0% 0.17 pp7.22% 0.13 pp
DII Holding10.38%9.24% 1.72 pp
Public Holding37% 0.16 pp34.44% 1.61 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: BROOKS and WOCKHARDT.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.